Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Standaert

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Neurology|December 10, 2003
Adenosine A2A receptor modulation of motor systems for symptomatic therapy in Parkinson's diseaseDavid G Standaert
The New England Journal of Medicine|April 10, 2024
GLP-1, Parkinson's Disease, and NeuroprotectionDavid G Standaert
IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society|July 9, 2003
Wearable technology's applications in Parkinson's diseaseDavid G Standaert
Neurobiology of Disease|January 12, 2011
Update on the pathology of dystoniaDavid G Standaert
Archives of Neurology|February 16, 2005
Applications of laser capture microdissection in the study of neurodegenerative diseaseDavid G Standaert
Movement Disorders : Official Journal of the Movement Disorder Society|October 26, 2017
What would Dr. James parkinson think today? Mutations in beta-glucocerebrosidase and risk of Parkinson's diseaseDavid G Standaert
Neurobiology of Disease|August 25, 2019
Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?Paolo Calabresi, David G Standaert
Neurologic Clinics|November 16, 2002
Inherited movement disordersNutan Sharma, David G Standaert
Journal of Neurochemistry|April 30, 2003
Subcellular segregation of distinct heteromeric NMDA glutamate receptors in the striatumAnthone W Dunah, David G Standaert
Movement Disorders : Official Journal of the Movement Disorder Society|February 16, 2011
Parkinson's disease, primates, and gene therapy: vive la différence?Travis B Lewis, David G Standaert
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Neurology|December 10, 2003
Adenosine A2A receptor modulation of motor systems for symptomatic therapy in Parkinson's diseaseDavid G Standaert
The New England Journal of Medicine|April 10, 2024
GLP-1, Parkinson's Disease, and NeuroprotectionDavid G Standaert
IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society|July 9, 2003
Wearable technology's applications in Parkinson's diseaseDavid G Standaert
Neurobiology of Disease|January 12, 2011
Update on the pathology of dystoniaDavid G Standaert
Archives of Neurology|February 16, 2005
Applications of laser capture microdissection in the study of neurodegenerative diseaseDavid G Standaert
Movement Disorders : Official Journal of the Movement Disorder Society|October 26, 2017
What would Dr. James parkinson think today? Mutations in beta-glucocerebrosidase and risk of Parkinson's diseaseDavid G Standaert
Neurobiology of Disease|August 25, 2019
Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?Paolo Calabresi, David G Standaert
Neurologic Clinics|November 16, 2002
Inherited movement disordersNutan Sharma, David G Standaert
Journal of Neurochemistry|April 30, 2003
Subcellular segregation of distinct heteromeric NMDA glutamate receptors in the striatumAnthone W Dunah, David G Standaert
Movement Disorders : Official Journal of the Movement Disorder Society|February 16, 2011
Parkinson's disease, primates, and gene therapy: vive la différence?Travis B Lewis, David G Standaert
Pageof 19